Nine companies now block their shares from OKXICE as Nasdaq opts out of tokenized trading
The list of companies refusing to let their stock trade as tokens on OKXICE, the 24/7 venue from OKX and NYSE owner ICE, has grown to nine, up from three last week. Nasdaq is keeping its own shares off the venue too. Together the objections cut about 14% from OKXICE’s planned roster before it has even announced a launch date.
- Verizon, UnitedHealth, AppLovin, Applied Digital, Rocket Lab and Applied Optoelectronics have joined Broadcom, Cerebras and CoreWeave in objecting to their shares trading on OKXICE.
- Nasdaq is opting its own stock out, citing the lack of real-time best prices and consolidated tape reporting, even though its own tokenized securities pilot was recently approved.
- The objection notices give no reasons and do not say whether the companies’ tokens will actually be kept off the venue.
- 9 of 63 Issuers objecting out of the companies OKXICE planned to list, about 14% of the roster
- 24/7 Trading hours, through Uniswap v4 pools on OKX’s X Layer, settled in USDC and USDT
- 1:1 Real shares held by a third-party tokenizer at a registered broker-dealer behind each token
The list tripled in a week
CCS reported last Friday that Cerebras Systems, CoreWeave and Broadcom had blocked tokenized versions of their shares on OKXICE. Six more names have now followed, according to Decrypt, and the new group is broader: a telecom giant in Verizon, the largest US health insurer in UnitedHealth, and a set of AI infrastructure and space names that are popular with retail traders.
Nasdaq is not on the objection list, but it is keeping its own shares off OKXICE. Its stated reason goes to market structure: the venue does not provide real-time best prices or report trades to the consolidated tape, the feed that ties US stock prices together across exchanges. That position sits next to Nasdaq’s own move into the space, after it won approval for a tokenized securities pilot of its own.
How OKXICE works, and why issuers might balk
OKXICE trades tokens that each represent one real share, held by a third-party tokenizer at a registered broker-dealer. Trading runs around the clock in Uniswap v4 pools on X Layer, OKX’s own chain, with settlement in USDC and USDT. It operates under the “Innovation Exemption” the SEC unveiled in September, which lets platforms offer tokenized stocks without registering as exchanges.
That exemption comes with trade-offs. OKXICE is not bound by Regulation NMS, the rule that sends orders to the best available price, and it does not have to provide fair access. Trading is capped at a fraction of each stock’s normal volume, and administrators can upgrade the smart contracts without advance notice. None of the nine issuers has said which of these points, if any, drove its objection.
Consent is the real bottleneck
A tokenized share is only as good as the real share behind it, and that gives issuers leverage that crypto-native assets never had to deal with. If a meaningful number of large companies decline, venues lose the very names that draw traders. Decrypt notes the pushback could spread beyond OKXICE to other stock-token products, including those offered through Robinhood, Kraken and Backed Finance, and to Uniswap, which was set to be a main source of liquidity.
The CCS read. Tokenized stocks were pitched as a technology problem. This week shows they are a permission problem. A venue that skips the best-price rule and lets admins change contracts overnight is a hard sell to a company’s investor relations team, and it only takes a few household names saying no to make the rest think twice. The likely winners are issuer-approved models like Nasdaq’s pilot, where the company and the exchange are on the same side. Expect OKXICE to start courting issuers with better price reporting rather than simply listing around them.
Next to watch: OKXICE’s launch date and final roster, whether objecting companies’ tokens actually stay off the venue, whether more S&P 500 names join the list, the timing of Nasdaq’s tokenized pilot, and any SEC guidance on issuer consent under the Innovation Exemption.